Clinical trial
Treatment of CML Patients With Imatinib and Hydroxyurea
NCT02480608 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of CML Patients With Imatinib and Hydroxyurea
- Lead sponsor
- University of Leipzig
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- May 31, 2013
- Enrollment
- 113 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.